Dr. Hayashi is the Associate Director of DILI within the Division of Hepatology and Nutrition, FDA. He received his Bachelor of Arts in microbiology at UCLA and MD at University of California (UC), San Diego. After completing residency and gastroenterology fellowship at UC Davis in Sacramento, California, he completed a clinical research fellowship in the Liver Diseases Section, NIDDK, NIH. He then completed a transplant fellowship at the University of Colorado, Denver. He completed a Master of Public Health at Saint Louis University (SLU), St.

Dr. Dina Halegoua-De Marzio is a full time transplant hepatologist and is currently a Professor of Medicine at Sidney Kimmel Medical College at Thomas Jefferson University. She completed her residency in internal medicine and fellowships in gastroenterology and transplant hepatology at Thomas Jefferson University Hospital (TJUH). She developed the first adult Fatty Liver Center in the Delaware Valley and currently serves as its director. She also serves as the Director of GI Research at TJUH and Associate Chief for the Division of Gastroenterology and Hepatology.

I am an Associate Professor at Beth Israel Deaconess Medical Center/Harvard Medical School. My studies focus on the mechanisms regulating immune tolerance in autoimmune liver diseases. The ultimate goal of my research is to devise new forms of immunotherapy for the treatment of these conditions.

Liver scientist with a strong research interest on uncovering the fundamental mechanisms driving the onset and progression of chronic liver disease, with particular interest in hepatic DAMPs, immune cell activation, and immune suppression across early and advanced disease stages.

I am a physician scientist and pediatric transplant hepatologist at Northwestern Feinberg School of Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago. My research focuses on basic and translational studies investigating the unfolded protein response (UPR) in murine models of cholestatic liver disease and pediatric cholestatic liver diseases.

Rohit Kohli MBBS, MS                                                           

MBBS-Armed Forces Medical College, University of Pune, India- 1993-1999

MS in Clinical Investigation, School of Public Health, Northwestern University, Chicago, IL- 2004-2006



Current Academic of Administrative Position:

Professor of Pediatrics (Clinical Scholar) University of Southern California,

Chief, Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital Los Angeles

Dr. Squires earned his medical degree from the University of Texas and went on to complete his training in general pediatrics at the Cincinnati Children's Hospital Medical Center (CCHMC). Following residency, he completed fellowships in both pediatric gastroenterology and pediatric advanced/transplant hepatology at CCHMC and completed a Masters in clinical and translational at the University of Cincinnati. Following completion of his training, Dr.

Dr. Ridruejo currently works as the Head of the Hepatology Section from the Department of Medicine at Center for Medical Education and Clinical Research, Norberto Quirno CEMIC in Ciudad Autónoma de Buenos Aires. He received his medical degree from Salvador University and completed his Internal Medicine residency at Center for Medical Education and Clinical Research, Norberto Quirno CEMIC and in University of Buenos Aires (UBA). He subsequently completed his training in Hepatology Baylor College of Medicine and in the Eugene B.

Maddie Kubiliun is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in steatotic liver disease, chronic liver disease, and transplantation medicine. Dr. Kubiliun earned her medical degree at the University of Miami in Florida and completed a residency in internal medicine at UT Southwestern Medical Center.

Dr. Ding is a William Warner Abercrombie professor of the Department of Pharmacology, Toxicology and Therapeutics at KUMC. The Ding laboratory has been working on the role of autophagy in alcohol and drug-induced liver injury since 2009. The Ding Lab is particularly interested in how autophagy selectively removes cellular damaged/excess organelles such as mitochondria and lipid droplets in hepatocytes. Dr. Ding has extensive expertise in organelle stress and quality control in cell death and innate immunity in the pathogenesis of alcohol-associated liver disease.